EW Healthcare Partners, L.P.
Related Filers (6)
- Essex Woodlands Fund IX-GP, L.P. (24)
- Essex Woodlands IX, LLC (24)
- Venus Concept Inc. (23)
- EW Healthcare Partners-A, L.P. (23)
- EyePoint Pharmaceuticals, Inc. (17)
- Axogen, Inc. (7)
- Show More ...
Other (5)
144
Tuesday, 8/22/2023
Filing for proposed sale of securities under Rule 144
D/A
Friday, 10/28/2016
Exempt (Private) Offering
D/A
Monday, 7/18/2016
Exempt (Private) Offering
D/A
Wednesday, 7/1/2015
Exempt (Private) Offering
D
Wednesday, 7/2/2014
Exempt (Private) Offering
Ownership (46)
SC 13D/A
Monday, 1/22/2024
Venus Concept Inc.: Major Shareholders
4
Friday, 1/19/2024
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 12/8/2023
EyePoint Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Monday, 10/23/2023
Venus Concept Inc.: Major Shareholders
4
Friday, 10/20/2023
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 9/15/2023
Venus Concept Inc.: Major Shareholders
4
Tuesday, 9/12/2023
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 9/6/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/6/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/1/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 8/30/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 8/30/2023
EyePoint Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 8/30/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/28/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/24/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 7/14/2023
Venus Concept Inc.: Major Shareholders
4
Thursday, 7/13/2023
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/24/2023
Venus Concept Inc.: Major Shareholders
4
Wednesday, 5/17/2023
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 11/30/2022
Venus Concept Inc.: Major Shareholders
SC 13D/A
Monday, 11/28/2022
Venus Concept Inc.: Major Shareholders
4
Tuesday, 11/22/2022
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 11/22/2022
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 2/3/2022
Venus Concept Inc.: Major Shareholders
4
Friday, 12/17/2021
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 2/12/2021
Venus Concept Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/9/2021
Axogen, Inc.: Major Shareholders
4
Thursday, 6/18/2020
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 3/31/2020
Venus Concept Inc.: Major Shareholders
4
Friday, 3/20/2020
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
Axogen, Inc.: Major Shareholders
SC 13D
Monday, 11/18/2019
Venus Concept Inc.: Major Shareholders
4
Friday, 11/8/2019
Venus Concept Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/8/2019
Venus Concept Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Wednesday, 2/13/2019
EyePoint Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/13/2019
AxoGen, Inc.: Major Shareholders
5
Wednesday, 2/13/2019
EyePoint Pharmaceuticals, Inc.: Annual statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 7/5/2018
EyePoint Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 7/3/2018
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Tuesday, 4/10/2018
EyePoint Pharmaceuticals, Inc.: Major Shareholders
3
Monday, 4/2/2018
EyePoint Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 4/2/2018
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 3/26/2018
AxoGen, Inc.: Major Shareholders
4
Tuesday, 11/21/2017
AxoGen, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/2/2015
AxoGen, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Wednesday, 9/2/2015
AxoGen, Inc.: Major Shareholders